Vancomycin
Overview
Vancomycin is a glycopeptide antibiotic used to treat serious bacterial infections by inhibiting bacterial cell wall synthesis. It is particularly effective against Gram-positive bacteria, including resistant strains like MRSA.
API suppliers (4)
Suppliers of Vancomycin evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.
Country recorded for 3 of 4 suppliers.
3 of 4 hold a GMP certificate on record in the EU or UK registers
- Zhejiang Medicine Co., Ltd.China1 active DMF
- CONCORD BIOTECH LTDIndia1 active DMF GMP on record
- LIVZON GROUP FUZHOU FUXING PHARMACEUTICAL CO LTD1 active DMF GMP on record
- Zhejiang Hisun Pharmaceutical Co., Ltd.China GMP on record
Patent & exclusivity (US)
Per the FDA Orange Book (97 approved US products), the latest listed US patent on Vancomycin expires 6 Nov 2035. Generic API sourcing typically opens up once these lapse.
Therapeutic areas
Do you supply Vancomycin? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.